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Abstract To investigate the prevalence, distribution, and
colonization burden of Staphylococcus aureus (S. aureus)
and MRSA in different body sites among people who inject
drugs (PWID) and compare it to a control group consisting
of non-injectors. In this cross-sectional survey, 49 active
PWID from the needle exchange program (NEP) in
Malmo¨, Sweden, and 60 non-injecting controls from an
emergency psychiatric inpatient ward at Malmo¨ Addiction
Centre were tested for S. aureus (including MRSA) by
culture, PCR, and MALDI-TOF. Samples were taken from
anterior nares, throat, perineum, and skin lesions if present.
Sixty-seven percent of the PWID were colonized with S.
aureus, compared to 50% of the controls (P = 0.08).
Perineal carriage was significantly more frequent among
PWID than in the control group [37 vs 17%, OR 2.96 (95%
CI 1.13–7.75), P = 0.03], also after adjusting for sex and
age in multivariate analysis [OR 4.01 (95% CI
1.34–12.03)]. Only one individual in the whole cohort
(NEP participant) tested positive for MRSA. PWID may be
more frequently colonized with S. aureus in the perineum
than non-injection drug users, and there was a trend indi-
cating more frequent overall S. aureus colonization in
PWID, as well as higher perineal colonization burden. No
indication of a high MRSA prevalence among PWID in
Sweden was noted. However, further MRSA prevalence
studies among PWID are needed. Knowledge about S.
aureus colonization is important for the prevention of S.
aureus infections with high morbidity in PWID.
Introduction
People who inject drugs (PWID) are at increased risk for
superficial and invasive infections with Staphylococcus
aureus (S. aureus), resulting in increased length of hospi-
talization, mortality and economic cost [16, 45]. In
microbiological studies, PWID are more frequently colo-
nized with S. aureus than the average population (35% of
recent injectors compared to 11% in healthy controls,
P\ 0.05) [42], with nasal colonization in 28–45%
[1, 17, 22]. Another concern regarding S. aureus is the
development and spread of methicillin-resistant S. aureus
(MRSA) [4]. While Sweden is still a low prevalence
country with MRSA prevalence of approximately 1% of S.
aureus isolates from blood cultures [41], MRSA is a major
issue globally [5]. Outbreaks of MRSA among PWID have
been reported [14] with carriage rates of 16–20% in pre-
vious studies [1, 17, 22].
Association between S. aureus nasal colonization and
increased risk for infection was reported in the 1930s [44],
and supported by several more recent studies
[4, 12, 20, 44, 45]. It is suggested that S. aureus infections
originate from endogenous nasal bacteria that are spread to
the skin, which in turn cause infection when the integrity of
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the skin is compromised [20]. von Eiff et al. [12] showed
that in approximately 80% of S. aureus bacteremia, the
pathogen was identical to the S. aureus stem colonizing the
subject’s nose.
S. aureus colonization (including MRSA) in extra-nasal
sites is less investigated. The most frequent sites of colo-
nization are considered to be the skin, the perineum and the
pharynx [44]. Several authors stress the need for more
studies, and suggest multi-body site sampling [9, 21].
Perineal colonization with S. aureus was first described in
the 1950s [34], but recent studies are sparse and the clinical
importance of perineal carriage in relation to nasal carriage
is still unclear.
In longitudinal studies, S. aureus carriage patterns have
been classified as persistent, intermittent or non-existent
[43, 47], with approximately 30% of humans being inter-
mittent nasal carriers [44]. However, figures are varying,
and nasal carriage was found in 44% in the general pop-
ulation of Malmo¨, Sweden, in 2011 [26]. In post-surgical
and hemodialysis patients, persistent nasal carriage of S.
aureus or MRSA has been shown to be a risk factor of S.
aureus infections [19, 28, 46].
Abundant bacterial growth, i.e. high S. aureus colo-
nization burden, has been associated with persistent nasal
carriage [39]. In a study by Mermel et al. [24], abundant
levels of nasal MRSA was associated with increased like-
lihood of extra-nasal colonization. Studies on bacterial
burden are very sparse, and show incoherent findings
regarding risk for infection [19, 38].
The primary aim of this study has been to investigate the
prevalence of S. aureus among PWID at a needle exchange
clinic, and to compare it to a control group consisting of non-
injectors. The second aim has been to examine the quanti-
tative level and body distribution of S. aureus colonization,
and to investigate the prevalence of MRSA in PWID.
Materials and Methods
Setting
The study was conducted at the Malmo¨ Needle Exchange
Program (Malmo¨ NEP). Malmo¨ NEP is located in the
Malmo¨ metropolitan area in Ska˚ne county, Sweden, which
has an estimated population of 350,000 inhabitants. A total
of 1130 individuals with injection drug abuse are estimated
to live in Ska˚ne county, and approximately 600 of them are
active visitors of the Malmo¨ NEP each year [15]. Malmo¨
NEP offers sterile injection equipment in exchange for
used equipment, as well as certain health care, and
surveillance and treatment of viral infections. The Malmo¨
NEP is a part of the Department of Infectious Diseases at
Ska˚ne University Hospital in Malmo¨.
A control group of non-injecting substance dependent
patients were recruited from Malmo¨ Addiction Centre
(MAC). MAC consists of three inpatient wards, and several
outpatient clinics. The control group was recruited from an
inpatient ward with 15 beds, treating patients in need of
acute detoxification or psychiatric stabilization. The ward
is part of the Department of Psychiatry in Malmo¨, and the
care given is thus not strictly somatic. In terms of hygiene
standards, patients use hospital clothes but there are no
routines concerning personal hygiene for inpatients.
Average duration from admission to discharge is four days.
Design
Participants in the Malmo¨ NEP were randomly invited to
participate in the study between May 2014 and September
2015. A control group consisting of hospitalized patients at
MAC were also recruited by random invitation. Written
informed consent was obtained from all study participants
in both groups. Exclusion criteria were psychiatric illness
or substance influence severe enough to prevent the patient
from providing informed consent. Participants in the con-
trol group were excluded if they had injected drugs or been
hospitalized abroad in the past 6 months. No compensation
for study participation was offered. The study was
approved by the Regional Ethical Review Board in Lund
(file number 2014/307).
Microbiological Methods and Data Collection
Samples were collected from the anterior nares, throat, per-
ineum and from skin lesions using Copan E-swabs (480CE;
Copan Italia, Brescia, Italy). Separate swabs were used for
the different body sites. Nasal, pharyngeal and skin lesion
samples were collected by NEP/MAC personnel. Partici-
pants in the control group were allowed to handle the swab
themselves, strictly supervised by MAC personnel. Perineal
samples were in almost 100% of cases collected by the
patients in both groups after thorough instructions. The first
swab was inserted 1 cm in each nostril and rotated thrice, the
second one was streaked twice on one of the tonsil and the
third one was streaked on the perineum three times. If there
were any skin lesions, they were cleansed prior to sampling
from the edges of the lesion. The swabs was stirred for 30 s in
the transport medium in separate tubes and thereafter with-
drawn. The tubes were forwarded to the Clinical Microbi-
ology Laboratory in Malmo¨ on a daily basis. After the
sampling was performed, the participants were interviewed
regarding demographic conditions. For the case group, basic
medical information regarding drug use was retrieved from
the patient chart.
One-hundred ll of each sample was added to a BBL
CHROMagar Staph aureus plate (CHROMagar, Paris,
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France) and 100 ll was added to a Brilliance MRSA 2 agar
plate (PO5196A; Oxoid, Basingstoke, United Kingdom).
The inoculum was spread on the plates with sterile glass
beads and incubated at 35 C. After 48 h, colonies with
typical color appearance (pink on BBL CHROMagar Staph
aureus plate and blue on Brilliance MRSA 2 agar plate)
were confirmed by a positive agglutination test (Pastorex
Staph Plus [Bio-Rad, Hercules, CA, USA]). Suspected
MRSA colonies were further verified by mecA PCR [32].
In case of growth of colonies with atypical color, Pastorex
agglutination and MALDI-TOF were used to rule out
atypical S. aureus [37]. The number of viable bacteria was
measured as colony forming units (CFU). Semi-quantita-
tive evaluation of S. aureus growth was made by counting
the CFUs, where n CFU[ 500 were considered as abun-
dant, 50–499 as intermediate, 1–49 as sparse and 0 as no
growth.
The amount of growth was later converted into a
hypothetic scale separating abundant growth (=3), from
intermediate (=2), sparse (=1) and no growth (=0). To
evaluate the total amount of colonization, an accumulative
score was calculated for each participant by summing up
the scores from each sampling site (nose, throat, perineum
and skin lesions) constructing a scale ranging from 0 to 12,
with 12 being the most abundantly colonized individuals.
The median score in the total amount of colonization was
subsequently found to be three, in both the case and control
group. Thus, patients with scores B3 were considered to be
sparsely colonized and scores C4 as abundantly colonized.
Statistical Analysis
Only one variable, overall colonization burden (i.e. S.
aureus present in any body site cultured), was recoded (see
above). To calculate statistical significance, v2 test for
dichotomous and Mann–Whitney test for continuous vari-
ables were conducted. Unadjusted logistic regression was
used for bivariate analysis of categorical variables with
more than two options. Variables with P\ 0.1 in bivariate
analysis were further assessed through multivariable
logistic regression analysis, adjusting for age and sex.
P values\ 0.05 were considered statistically significant.




Forty-nine patients from Malmo¨ NEP (69% male, median
age 48 years) and 60 control patients from MAC (68% male,
median age 52 years) were enrolled in the study (Table 1).
Illicit drug use was reported by the case group. Amphetamine
and heroin were reported as main drug by 61 and 22%,
respectively. Median duration of injection drug use was
22 years (range 1–45 years). Housing status was reported by
the case group, and 16% reported unstable housing. Skin
lesions were significantly more common in the case group
compared to the control group (18 vs 3%, P = 0.03).
Overall S. aureus and MRSA Colonization Rates
Colonization in at least one body site, overall S. aureus
colonization rate, was detected in 67% of PWID, and in
50% of control patients (P = 0.08 in bivariate analysis)
(Table 2). This difference was not statistically significant
in multivariate analysis [OR 1.90 (95% CI 0.82–4.44)]
(Table 3). Only one individual (NEP participant) in the
total cohort (1%) tested positive for MRSA.
S. aureus Distribution in Nasal and Extra-Nasal
Sites
S. aureus detection rates in specific body sites are presented
in Table 2. Fourteen patients in the case group chose to
refrain from perineal sampling, and were only included in
the nose/throat/skin lesion calculations.
The anterior nares were the most common site of colo-
nization in both groups, 41% in the case group and 35% in the
control group, followed by the throat with a 37% detection
rate among PWID and 33% in the control group. Perineal
colonization was significantly associated with injection drug
use in bivariate analysis [37% in PWID vs 17% in controls,
OR 2.96 (95% CI 1.13–7.75), P = 0.03]. This association
remained in multivariate analysis (Table 4), when adjusting
for sex and age (OR 4.01 [95% CI 1.34–12.03], P = 0.01).
Regarding colonization in one body site only, the throat
was the most common site in both groups (11 vs 12%).
Among the drug injection users it was most common to be
colonized in the three carriage sites concurrently, whereas
among the non-injectors in two sites (nose and throat). In
both groups there were a few individuals with perineal
colonization only. The number of colonized locals did,
however, not differ significantly between PWID and con-
trols. Several study participants, both at Malmo¨ NEP (8 of
35, 23%) and in the control group (9 of 60, 15%) were
colonized in extra-nasal sites only.
Semi-Quantitative S. aureus Colonization Burden
Bacterial burden in different body sites is presented in
Table 5, for case and control group respectively. The
prevalence of abundant S. aureus colonization in the PWID
group was found to be 16% (N = 8) in the nares, 4%
(N = 2) in the throat, and 11% (N = 4) in the perineum.
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There was no significant difference between the PWID
group and control group in terms of abundant colonization
of any specific body site, nor in the over-all colonization
burden (as defined in the Methods section). However, there
was a trend towards association between abundant perineal
colonization and participation in Malmo¨ NEP [OR 4.55
(95% CI 0.77–26.68), P = 0.09] in bivariate analysis. Due
to a very small number of subjects in the control group
(N = 2), multivariate analysis was not conducted.
Discussion
The present findings with significantly more frequent per-
ineal carriage of S. aureus in PWID than in controls are
data that to our knowledge are not presented before.
Overall S. aureus colonization rate in PWID has been
assessed previously. The high percentage of 67% S. aureus
culture positive PWID at Malmo¨ NEP is, however, not in
agreement with the 39% obtained by Bassetti et al., who
also found a lower prevalence rate when comparing PWID
with non-injectors [6]. These contrasting results may partly
be explained by the fact that the maintenance program
studied by Bassetti et al. also assisted in injections, in
addition to the provision of sterile equipment, while no
supervised or assisted injections take place at Malmo¨ NEP.
One interpretation of these results could be that it is
injections under unclean conditions, rather than the injec-
tions themselves, that cause S. aureus colonization.
Homelessness is an important factor predisposing for
poor hygiene and suboptimal injection conditions. In this
study, 16% of PWID reported current unstable housing,
which is comparable to two previous studies from Malmo¨
NEP where 40% of PWID reported unstable housing in the
past 6 months [10], and 11% of female PWID reported
being currently homeless or living in a shelter [33]. In an
international perspective, these numbers are low. More
than 60% of PWID reported unstable housing in studies
from Canada [23] and the U.S. [36]. It is notable that skin
lesions were significantly more common among PWID
than among controls. This finding is in agreement with
previous studies showing that PWID living under poor
conditions are at increased risk also for other skin lesions
than injections. Common health hazards among homeless
people are dermatological problems such as skin infections,
eczemas and trauma as well as diseases carried by lice and
scabies [3, 31, 40]. It remains unclear whether injections as
such increase the S. aureus colonization burden among
PWID, or if poor living conditions, cramped housing and
frequent skin lesions are more important factors, and more
research is necessary to further assess main routes of col-
onization and infection.
S. aureus often disseminate from a site of asymptomatic
colonization to cause infections, and correlations between
commensal carriage and bouts of actual disease have been
frequently reported. Intervention programs with nasal
decolonization and chlorhexidine body washes decrease S.
aureus infection rates in surgical and dialysis patients
[2, 30]. In the light of PWIDs frequent overall S. aureus
colonization [1, 17, 22, 42] and high infection rates
[16, 45], this group might benefit from similar interven-
tions. Previous studies on chlorhexidine wash as a means of
Table 1 Population characteristics
Characteristic PWID at Malmo¨ NEP
N (%) Total N = 49
Controls at MAC N (%)
Total N = 60
P value
Biological sex
Male (total N = 75, 69%) 34 (69%) 41 (68%) 0.91
Female (total N = 34, 31%) 15 (31%) 19 (32%)
Age in years/median (range) 48 (23–68) 52 (19–77) 0.01*
Subjects with skin lesions (total N = 11, 10%) 9 (18%) 2 (3%) 0.03*
Main drug
Amphetamine 30 (61%) NA
Heroin 11 (22%) NA




Duration of injection drug use (year)/median (range) 22 (1–45) NA
Unstable housing 8 (16) NA
N = 49 people who inject drugs (PWID) at Malmo¨ needle exchange program, and N = 60 non-injecting substance dependent controls from
Malmo¨ Addiction Centre (MAC). Bivariate analysis with v2 test (dichotomous variables)/Mann–Whitney test (continuous variables)
* P\ 0.05
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Table 2 Bacterial colonization and body distribution with S. aureus and MRSA
Characteristic PWID at Malmo¨ NEP
N (% of valid answers)
Controls at MAC N (%
of valid answers)
Sample total
N (% of total
valid answers)
OR (95% CI) P value
S. aureus colonization (any body site)
Yes 29 (67%) 30 (50%) 58 (56%) 2.07 (0.92–4.68) 0.08?
No 14 (33%) 30 (50%) 45 (44%)
Missing/excluded 6 excluded – 6 excluded
Total valids 43 (100%) 60 (100%) 103 (100%)
MRSA colonization (any body site)
Yes 1 (3%) 0 1 (1%) NA NA
No 34 (97%) 60 (100%) 94 (99%)
Missing/excluded 14 excluded – 14 excluded
Total valids 35 (100%) 60 (100%) 95 (100%)
S. aureus colonization in nares
Yes 20 (41%) 21 (35%) 41 (38%) 1.28 (0.59–2.79) 0.53
No 29 (59%) 39 (65%) 68 (62%)
Total valids 49 (100%) 60 (100%) 109 (100%)
S. aureus colonization in throat
Yes 18 (37%) 20 (33%) 38 (35%) 1.16 (0.53–2.56) 0.71
No 31 (63%) 40 (67%) 71 (65%)
Total valids 49 (100%) 60 (100%) 109 (100%)
S. aureus colonization in perineum
Yes 13 (37%) 10 (17%) 23 (24%) 2.96 (1.13–7.75) 0.03*
No 22 (63%) 50 (83%) 72 (76%)
Missing/excluded 14 excluded – 14 excluded
Total valids 35 (100%) 60 (100%) 95 (100%)
S. aureus colonization in skin lesions
Yes 7 (78%) 1 (50%) 8 (73%) 3.50 (0.15–84.69) 0.49#
No 2 (22%) 1 (50%) 3 (27%)
Missing/excluded 40 excluded 58 excluded 98 excluded
Total valids 9 (100%) 2 (100%) 11 (100%)
Nr of S. aureus-colonized locals
0-Neither nares, throat or perineum 15 (43%) 30 (50%) 45 (47%)
1-Colonization in one body site 8 (23%) 13 (22%) 21 (22%) 1.23 (0.42–3.61) 0.71
Nares only 1 (3%) 4 (7%) 5 (5%)
Throat only 4 (11%) 7 (12%) 11 (12%)
Perineum only 3 (9%) 2 (3%) 5 (5%)
2-Colonization in two body sites 7 (20%) 13 (22%) 20 (21%) 1.08 (0.36–3.26) 0.90
Nares and throat 2 (6%) 9 (15%) 11 (12%)
Nares and perineum 4 (11%) 4 (7%) 8 (8%)
Throat and perineum 1 (3%) 0 1 (1%)
3-Colonization in nares, throat and perineum 5 (14%) 4 (7%) 9 (9%) 2.50 (0.58–10.70) 0.22
Missing/excluded 14 excluded – 14 excluded
Total valids 35 (100%) 60 (100%) 95 (100%)
N = 49 people who inject drugs (PWID) at Malmo¨ needle exchange program, and N = 60 non-injecting substance dependent controls from
Malmo¨ Addiction Centre (MAC). Bivariate analysis with v2 test (dichotomous variables)/unadjusted logistic regression (categorical variables
with more than two options)
? P\ 0.1, * P\ 0.05
# Fisher’s exact test (N\ 2)
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decreasing skin and soft tissue infections (SSTI) in
American recruits did not show any significant reduction of
the SSTI frequency [13], but was significantly associated
with lower frequency of nasal MRSA colonization [25].
These results indicate that PWID, a high-risk population
with repeated skin lesions, might benefit from a similar
intervention, which to our knowledge has not been con-
ducted. However, a pilot study investigating skin and
needle hygiene intervention showed promising results in
terms of skin and needle behavioral skills as well as the rate
of bacterial infections [29].
Nasal S. aureus colonization rate in the current study
was 41% in PWID, which is within the range of 28–45%
previously reported [1, 17, 22]. The most common site of
colonization, independent of carriage in other sites, was the
anterior nares. But regarding colonization in one sole body
site, the throat was the most common, which also has been
noted by other studies from Sweden [27]. Several subjects,
both at Malmo¨ NEP and in the control group, were colo-
nized in extra-nasal sites only.
Interestingly, perineal S. aureus carriage was statisti-
cally more frequent in PWID in comparison to non-injec-
tors (37 vs 17%), which could be a marker for a more
extended carriage, and higher colonization burden. Perineal
colonization frequency in the case group as well as the
control group was higher than in a previous study from
1964 detecting perineal carriage in 13% [7] among 3000
unselected patients admitted to a medical ward. A handful
of the individuals (5%) in our cohort were found to be
colonized in the perineum only. These results are in
agreement with other reports and sole perineal carriage; 3%
in a study from 1964 [7] and 8% in one from 1991 [11].
These findings on extra-nasal colonization may be of
value when developing clinical routines regarding screen-
ing or prophylactic treatment, since screening for MRSA
not always include sampling the throat [35] or the per-
ineum. However, it remains to be elucidated whether
throat, perineal or multi-local colonization is associated
with skin carriage, endogenous infections and transmission
to other individuals or not. Future longitudinal studies to
evaluate whether S. aureus colonization in extra-nasal sites
persists over time, and to what extent it’s associated to S.
aureus infections should be of value.
To our knowledge, this study is the first to present semi-
quantification of S. aureus in PWID through bacterial
cultures. A high level of nasal S. aureus colonization in
only one swab has pointed at persistent carriage of S.
aureus which in turn implicates increased risk of infection
[28]. Larger studies are however necessary to evaluate
possible associations between high colonization burden,
immune status, infection risk and multi-site colonization.
Only one PWID in this study was colonized with
MRSA, which is considerably lower than the rates of
16–20% reported by previous studies from high endemic
areas [1, 17, 22]. Our results are in agreement with the low
frequency of MRSA in the general population in Sweden
Table 3 Variables associated with overall S. aureus colonization
Variables MODEL 1a OR (95% CI) MODEL 2b AOR (95% CI)
Injection drug use (participation in Malmo¨ NEP vs controls at MAC) 2.07 (0.92–4.68) 1.90 (0.82–4.44)
Age in years 0.99 (0.95–1.03)
Sex (Male vs Female) 0.99 (0.38–2.57)
Unadjusted and adjusted logistic regression analysis. N = 103 (excluded N = 6)
* P\ 0.05
a Unadjusted
b Adjusted for age and sex
Table 4 Variables associated with perineal S. aureus colonization
Variables MODEL 1a OR (95% CI) MODEL 2b AOR (95% CI)
Injection drug use (participation in Malmo¨ NEP vs controls at MAC) 2.96 (1.13–7.75)* 4.01 (1.34–12.03)*
Age in years 1.04 (0.99–1.09)
Sex (Male vs Female) 2.71 (0.86–8.55)
Unadjusted and adjusted logistic regression analysis. N = 95 (excluded N = 14)
* P\ 0.05
a Unadjusted
b Adjusted for age and sex
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[41] indicating that PWID are not an undetected reservoir
of MRSA. However, due to the small sample size, further
studies are needed to confirm these primary findings.
This study has limitations that need to be taken into
consideration when interpreting the results. First, the
sample size is relatively small. Lack of time or interest
were often mentioned when a reason was given for
refraining from study participation. A quarter of the NEP
participants included in the study declined perineal sam-
pling due to lack of time, which may affect the results since
the total sample size was small. Furthermore, no compen-
sation for participation was given which also may have
affected the choice of partaking. A certain selection of
study participants may also occur when recruiting from a
NEP, and the results from this study cannot be assumed to
concern PWID in general. It has been noted previously that
NEP participation might attract PWID with poorer health
than the average PWID population [8]. However, we
consider the risk of selection bias to be relatively low. The
gender distribution, as well as distribution of main drug,
among the 49 study participants was similar to that of the
entire NEP participant community [oral personal commu-
nication, M. Alanko Blome´ MD, Medical supervisor of the
Malmo¨ NEP, January 2016]. There were no selection cri-
teria when inviting participants to the study, and no
information about the study that, to our knowledge, would
create bias between study participants and non-participants.
Second, as in all cross-sectional studies, our results may
somewhat be affected by the fact that only one single
culture was obtained in each individual. The results do
show a significantly more frequent perineal S. aureus col-
onization among PWID compared to controls, but this
finding is based on sampling at one specific time point and
its’ relevance should therefore be viewed with caution.
Also, we did not have access to hospital chart data on
previous or current clinically significant infections, or
Table 5 Semi-quantitative S. aureus colonization burden in different body sites
Characteristic PWID at Malmo¨ NEP
N (% of valid answers)
Controls at MAC N (%
of valid answers)
Sample total
N (% of total
valid answers)
OR (95% CI) P value
S. aureus colonization burden in nares
No colonization 29 (59%) 39 (65%) 68 (62%)
Sparse growth 10 (20%) 5 (8%) 15 (14%) 2.69 (0.83–8.72) 0.10
Intermediate growth 2 (4%) 7 (12%) 9 (9%) 0.38 (0.07–1.99) 0.25
Abundant growth 8 (16%) 9 (15%) 17 (16%) 1.20 (0.41–3.47) 0.74
Total valids 49 (100%) 60 (100%) 109 (100%)
S. aureus colonization burden in throat
No colonization 31 (63%) 40 (67%) 71 (65%)
Sparse growth 12 (25%) 17 (28%) 29 (27%) 0.91 (0.38–2.19) 0.83
Intermediate growth 4 (8%) 2 (3%) 6 (6%) 2.58 (0.44–15.02) 0.29
Abundant growth 2 (4%) 1 (2%) 3 (3%) 2.58 (0.22–29.78) 0.45
Total valids 49 (100%) 60 (100%) 109 (100%)
S. aureus colonization burden in perineum
No colonization 22 (63%) 50 (83%) 72 (76%)
Sparse growth 7 (20%) 7 (12%) 14 (15%) 2.27 (0.71–7.26) 0.17
Intermediate growth 2 (6%) 1 (2%) 3 (3%) 4.55 (0.39–52.79) 0.23
Abundant growth 4 (11%) 2 (3%) 6 (6%) 4.55 (0.77–26.68) 0.09*
Missing/excluded 14 excluded – 14 excluded
Total valids 35 (100%) 60 (100%) 95 (100%)
Full-body S. aureus colonization burden
Abundant (median\ , i.e. 3\) 8 (23%) 9 (15%) 17 (18%) 1.70 (0.58–4.85) 0.34
Sparse (up to median, i.e. 3 or less) 27 (77%) 51 (85%) 78 (82%)
Missing/excluded 14 excluded – 14 excluded
Total valids 35 (100%) 60 (100%) 95 (100%)
N = 49 people who inject drugs (PWID) at Malmo¨ needle exchange program, and N = 60 non-injecting substance dependent controls from
Malmo¨ Addiction Centre (MAC). Bivariate analysis with v2 test (dichotomous variables)/unadjusted logistic regression analysis (categorical
variables with more than two options)
* P\ 0.1
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antibiotic use. This limitation of patient data do not allow a
more thorough analysis of reasons for colonization patterns
among PWID and controls, as well as the clinical impor-
tance thereof.
Finally, microbiological testing was subject to a limi-
tation since the Clinical Microbiology laboratory performs
spa-typing and determines the presence of the PVL-gene
on MRSA isolates but not on MSSA. Since the samples
resulted only in one MRSA isolate, we were not able to
assess PVL-gene and spa-type, something that would have
added deeper understanding of possible clonal S. aureus
spread among PWID (through spa-typing) as well as fac-
tors associated with invasive disease (PVL detection).
A strength in the study is the control group consisting of
non-injectors with severe substance use disorders in need
of hospital care. By using this control group rather than
healthy subjects we try to minimize bias in terms of
socioeconomic factors, general living conditions and
nutritional status. We do not believe that receiving inpa-
tient care was significantly improving the control subjects’
hygiene standards, since average length of hospital treat-
ment is only four days, and the ward does not have specific
routines for patients’ personal hygiene. The use of semi-
quantitative cultures has, to our knowledge, never have
been applied in this group previously and add interesting
information.
In conclusion, PWID are significantly more frequently
colonized with S. aureus in the perineum than non-injec-
tors, and there’s a trend indicating that PWID are also more
frequently S. aureus colonized in general, and have higher
perineal colonization burden. This study does not indicate a
high prevalence of MRSA among PWID in southern
Sweden, but due to small number of participants further
studies are needed to confirm these primary findings. The
impact of high frequency of perineal carriage is currently
unclear and should be further explored, investigating larger
populations with repeated cultures to yield deeper insight
in the dynamics of S. aureus colonization and its correla-
tion to S. aureus-mediated disease.
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